Protagenic Therapeutics, Inc.\new Annual Return On Assets in % from 2015 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Protagenic Therapeutics, Inc.\new quarterly/annual Return On Assets history and growth rate from 2015 to 2023.
  • Protagenic Therapeutics, Inc.\new Return On Assets for the quarter ending September 30, 2024 was -229 %, a 309% decline year-over-year.
  • Protagenic Therapeutics, Inc.\new annual Return On Assets for 2023 was -82.2 %, a 103% decline from 2022.
  • Protagenic Therapeutics, Inc.\new annual Return On Assets for 2022 was -40.5 %, a 21.7% increase from 2021.
  • Protagenic Therapeutics, Inc.\new annual Return On Assets for 2021 was -51.7 %, a 80.4% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -82.2 -41.7 -103% Jan 1, 2023 Dec 31, 2023
2022 -40.5 +11.2 +21.7% Jan 1, 2022 Dec 31, 2022
2021 -51.7 +213 +80.4% Jan 1, 2021 Dec 31, 2021
2020 -264 +95.8 +26.6% Jan 1, 2020 Dec 31, 2020
2019 -360 -119 -49.6% Jan 1, 2019 Dec 31, 2019
2018 -241 -143 -146% Jan 1, 2018 Dec 31, 2018
2017 -98 -34.3 -53.8% Jan 1, 2017 Dec 31, 2017
2016 -63.7 +1.1K +94.5% Jan 1, 2016 Dec 31, 2016
2015 -1.16K Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.